Evidence map›Paper›PMID 31315859›Full record

ArticleBMJ open2019

National medical expenditures by smoking status in American adults: an application of Manning's two-stage model to nationally representative data.

David I Swedler, Ted R Miller, Bina Ali, Geetha Waeher, Steven L Bernstein

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

David I SwedlerPacific Institute for Research and Evaluation, Calverton, Maryland, USA.
Ted R MillerPacific Institute for Research and Evaluation, Calverton, Maryland, USA.
Bina AliPacific Institute for Research and Evaluation, Calverton, Maryland, USA.
Geetha WaeherPacific Institute for Research and Evaluation, Calverton, Maryland, USA.
Steven L BernsteinDepartment of Emergency Medicine; Department of Health Policy, Yale University, New Haven, Connecticut, USA.
Institute for Research and Evaluation · USPacific Institute For Research and Evaluation · USYale New Haven Health System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Optimizing Tobacco Dependence Treatment in the Emergency DepartmentR01CA201873 · NCI · YALE UNIVERSITY · PI DZIURA, JAMES DAVID · 2016 to 2019
$2.7M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA201873
6 · The paper itself

Abstract

objectivesTo assess the medical expenditures of American adults by their smoking status-Current, Former or Never smokers. We update these expenditures through 2015 controlling for personal characteristics and medical history and assess the impact of years-since-quitting and decade of life. SETTING AND

participantsWeighted sample of American adults, 2011-2015. The linked National Health Interview Survey (NHIS) and Medical Expenditure Panel Survey (MEPS) are annual weighted representations of approximately 250 million adults. Sampling of NHIS is multistage with data collected throughout the year. PRIMARY OUTCOME MEASURES: Using data from NHIS and MEPS, we collected demographic data, self-reported medical history and current smoking status. Smoking status was designated as Never, Current and Former, along with years-since-quitting. Total medical expenditures were collected from MEPS for 2011-2015. We used Manning's two-part model to estimate average expenditures per individual and marginal costs for individuals at all levels of smoking status.

resultsAmerican adults averaged US$4830 in average medical expenditures. Never smokers (US$4360, 95% CI 4154.3 to 4566.3), had lower expenditures than Current (US$5244, 95% CI 4707.9 to 5580.3) and Former (US$5590, 95% CI 5267.4 to 5913.5) smokers. CI for Current and Former smokers overlapped. Results were similarly significant when controlling for disease history. Years-since-quitting did not affect expenditures. In each decade of adult life, Former smokers had the highest annual medical expenditures, followed by Current and then Never smokers.

conclusionsWe updated annual medical expenditures during the Affordable Care Act era by smoking status using the current best practice model. While we identify Former smokers as having higher medical expenditures than Current smokers, we do not examine how care-seeking behaviour varies between levels of each risk factor.

Indexed as

AdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHealth Care SurveysHealth ExpendituresHealth SurveysHumansMaleMiddle AgedModels, EconomicPatient Protection and Affordable Care ActSmokingUnited Statesaffordable care acthealth economicspublic health

Identifiers

PMID31315859
PMCPMC6661572
OpenAlexW2956911363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.